NOTE 19 – Stock-Based Compensation

 

The Company utilizes certain stock incentive plans as long-term retention programs intended to attract, retain, and provide incentives for key employees and non-employee directors in the form of incentive and non-qualified stock options, restricted stock, and restricted stock units. Shares are granted under plans approved by the Company’s shareholders. As of December 31, 2025, there were 204,531 shares available for grant under the 2020 Southern First Bancshares, Inc. Equity Incentive Plan.

 

Compensation cost is recognized for stock options and restricted stock awards issued to employees and non-employee directors and is measured as the fair value of these awards on their date of grant. A Black-Scholes model is utilized to estimate the fair value of stock options, while the market price of the Company’s common stock at the date of grant is used as the fair value of restricted stock awards. Compensation cost is recognized over the required service period, generally defined as the vesting period for stock option and restricted stock awards.

 

Stock-based compensation expense was recorded as follows:

 

             
  For the years ended December 31, 
(dollars in thousands)  2025   2024   2023 
Stock option expense  $33    374    528 
Restricted stock grant expense   2,239    1,909    1,415 
Total stock-based compensation expense  $2,272    2,283    1,943 

 

Stock Options

 

All stock options have an exercise price that is equal to the closing fair market value of the Company’s stock on the date the options were granted. Options granted under the plans generally vest over a four-year period and expire 10 years from the grant date. The Company did not grant any stock options during the years ended December 31, 2025, 2024, or 2023.

 

At December 31, 2025, there was no remaining compensation cost related to nonvested stock option grants. The fair value of stock option grants that vested during 2025, 2024, and 2023 was $390,000, $576,000 and $846,000, respectively.

 

A summary of the status of the stock option plan and changes for the period is presented below:

 

         
  For the years ended December 31, 
   2025   2024   2023 
   Shares   Weighted
average
exercise
price
   Weighted Average Remaining Contractual Life   Shares   Weighted
average
exercise
price
   Weighted Average Remaining Contractual Life   Shares   Weighted
average
exercise
price
   Weighted Average Remaining Contractual Life 
Outstanding at beginning of year   312,599   $36.34         331,349   $35.51         427,224   $34.32      
Granted   -    -         -    -         -    -      
Exercised   (68,500)   29.82         (15,250)   17.17         (27,250)   20.18      
Forfeited or expired   (3,500)   42.30         (3,500)   41.55         (68,625)   34.15      
Outstanding at end of year   240,599   $38.11    3.6 years    312,599   $36.34    4.1 years    331,349   $35.51    4.9 years 
Options exercisable at
year-end
   240,599   $38.11    3.6 years    288,849   $36.00    4.0 years    267,376   $34.48    4.5 years 
Weighted average fair value of options granted during the year       $-             $-             $-      
Shares available for grant   204,531              258,622              319,058           

 

The aggregate intrinsic value (the difference between the Company’s closing stock price on the last trading day of the year and the exercise price, multiplied by the number of in-the-money options) of 240,599 and 312,599 stock options outstanding at December 31, 2025 and 2024 was $3.2 million and $1.4 million, respectively. The aggregate intrinsic value of 240,599 and 288,849 stock options exercisable at December 31, 2025 and 2024 was $3.2 million and $1.4 million, respectively.

 

Restricted Stock Grants

 

Shares of restricted stock granted to employees under the stock plans are subject to restrictions as to continuous employment for a specified time period following the date of grant. Under the 2020 Southern First Bancshares, Inc. Equity Incentive Plan, the Company may grant both restricted stock awards and restricted stock units. Restricted stock awards are issued and outstanding upon grant and restricted stock units are issued and outstanding upon vesting. During the vesting period, holders of restricted stock awards are entitled to full voting rights and dividends, if and when declared, while holders of restricted stock units have no rights to vote or dividends, if and when declared.

 

At December 31, 2025, there was $3.7 million of total unrecognized compensation cost related to nonvested restricted stock grants. The cost is expected to be recognized over a weighted-average period of 2.4 years.

 

A summary of the status of the Company’s nonvested restricted stock and changes for the years ended December 31, 2025, 2024, and 2023 is as follows:

 

     
  December 31, 
   2025   2024   2023 
   Restricted
Shares
   Weighted
Average
Grant-Date
Fair Value
   Restricted
Shares
   Weighted
Average
Grant-Date
Fair Value
   Restricted
Shares
   Weighted
Average
Grant-Date
Fair Value
 
Nonvested at beginning of year   139,851   $40.85    109,533   $44.40    80,337   $52.53 
Granted   65,685    37.09    65,373    36.47    69,880    37.12 
Vested   (44,559)   41.91    (30,118)   44.72    (21,695)   48.95 
Forfeited   (10,594)   40.74    (4,937)   37.95    (18,989)   46.83 
Nonvested at end of year   150,383   $38.90    139,851   $40.85    109,533   $44.40 

Historical Timeline

Fiscal YearFiled
2025Feb 24, 2026Showing above
2024Mar 3, 2025
2023Mar 5, 2024
2022Feb 13, 2023

About Stock Compensation Disclosures

Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.

Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.